Literature DB >> 7859135

Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients.

U Süttmann1, J Ockenga, O Selberg, L Hoogestraat, H Deicher, M J Müller.   

Abstract

Although malnutrition and wasting are known features of human immunodeficiency virus (HIV) infection, their incidence and possible association with immunologic impairment are largely unknown, as is the prognostic value of the nutritional state. Nutritional, clinical, and immunologic parameters were measured in 100 outpatients in different stages of HIV infection. In addition, 39 patients with AIDS were prospectively followed for a mean period of 343 (range, 53-650) days. Sixty-three percent of the patients showed evidence of malnutrition, 21% suffered from wasting. A reduced body cell mass and decreased serum albumin levels were observed in 32 and 14%, respectively, predominantly in more advanced disease stages. Fourteen of 39 AIDS patients died after a mean survival of 212 days. Survivors showed significantly larger initial body cell mass values and higher initial serum albumin levels compared with nonsurvivors, whereas CD4+ lymphocyte counts, disease complications, and medication were all similar in both groups. Kaplan-Meier analyses revealed a significantly prolonged survival in patients with a body cell mass > 30% of body weight or serum albumin levels exceeding 30 g/L. Factor analyses indicated that the parameters of nutritional state were independent from each other and from CD4+ lymphocyte counts. Malnutrition occurs frequently during HIV infection and increases with disease progress. It strongly predicts patient survival independent of CD4+ lymphocyte counts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7859135     DOI: 10.1097/00042560-199503010-00004

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  54 in total

1.  Pharmacokinetics of rifabutin in HIV-infected patients with or without wasting syndrome.

Authors:  G Gatti; A Di Biagio; C R De Pascalis; M Guerra; M Bassetti; D Bassetti
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

2.  Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).

Authors:  R Thiébaut ; D Malvy; C Marimoutou; F Davis
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

3.  Effect of HIV infection on body composition and fat distribution in Rwandan women.

Authors:  Eugene Mutimura; Kathryn Anastos; Mardge Cohen; Agnes Binagwaho; Donald P Kotler
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2010 May-Jun

4.  Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease.

Authors:  M A McNurlan; P J Garlick; R T Steigbigel; K A DeCristofaro; R A Frost; C H Lang; R W Johnson; A M Santasier; C J Cabahug; J Fuhrer; M C Gelato
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

5.  Semiurgent endoscopic PEG tube replacement as a treatment for early initial PEG tube dislodgement in the immune-compromised patient.

Authors:  David I Gaines; Mark H Delegge
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

6.  Skeletal and cardiac myopathy in HIV-1 transgenic rats.

Authors:  Anne M Pruznak; Ly Hong-Brown; Rachel Lantry; Pengxiang She; Robert A Frost; Thomas C Vary; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-19       Impact factor: 4.310

7.  Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.

Authors:  Carl Grunfeld; Donald P Kotler; Donna K Arnett; Julian M Falutz; Steven M Haffner; Paul Hruz; Henry Masur; James B Meigs; Kathleen Mulligan; Peter Reiss; Katherine Samaras
Journal:  Circulation       Date:  2008-06-19       Impact factor: 29.690

Review 8.  Measurement and analysis of unbound drug concentrations.

Authors:  J D Wright; F D Boudinot; M R Ujhelyi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

Review 9.  Macronutrient supplementation for malnourished HIV-infected adults: a review of the evidence in resource-adequate and resource-constrained settings.

Authors:  John R Koethe; Benjamin H Chi; Karen M Megazzini; Douglas C Heimburger; Jeffrey S A Stringer
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

10.  Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa.

Authors:  Kwonjune J Seung; David B Omatayo; Salmaan Keshavjee; Jennifer J Furin; Paul E Farmer; Hind Satti
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.